高级检索
当前位置: 首页 > 详情页

Hepatic splenosis: Rare yet important - A case report and literature review

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Chongqing Univ, Chongqing Canc Inst, Key Lab Biorheol Sci & Technol, Minist Educ,Canc Hosp, Chongqing, Peoples R China [2]Chongqing Canc Hosp, Chongqing, Peoples R China [3]Huazhong Univ Sci & Technol,Tongji Med Coll,Tongji Hosp,Inst Organ Transplantat,Key Lab,Minist Hlth,Wuhan,Hubei,Peoples R China [4]Huazhong Univ Sci & Technol,Tongji Hosp,Tongji Med Coll,Minist Educ,Wuhan,Hubei,Peoples R China
出处:
ISSN:

关键词: Hepatic splenosis diagnosis treatment

摘要:
Hepatic splenosis is an uncommon condition that occurs following traumatic splenic rupture or splenectomy. The case of a 41-year-old male patient with multiple isolated liver masses indistinguishable from primary and metastatic liver tumours is reported. Following laparotomy, the liver lesions were resected and histopathology confirmed a diagnosis of hepatic splenosis. At an 18-month follow-up examination, no abnormalities in routine blood test, liver function, and liver computed tomography (CT) scanning were observed. After review of the literature, the following diagnostic criteria for hepatic splenosis are proposed: (1) a history of splenic trauma or splenectomy; (2) lesion(s) with a surrounding rim, particularly near the liver capsule identified by CT scanning; (3) findings on superparamagnetic iron oxide-enhanced magnetic resonance imaging or technetium-99m heat-damaged red cell scanning; and (4) histopathological findings (needle biopsy or surgical pathology). The following diagnostic process is also proposed: suspect diagnosis when criteria 1 and 2 are met; make diagnosis when criterion 3 is met; confirm diagnosis when criterion 4 is met. Laparotomy is recommended for either diagnosis or treatment when invasive procedures are necessary.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 药学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 药学
JCR分区:
出版当年[2017]版:
Q4 PHARMACOLOGY & PHARMACY Q4 MEDICINE, RESEARCH & EXPERIMENTAL
最新[2024]版:
Q3 MEDICINE, RESEARCH & EXPERIMENTAL Q4 PHARMACOLOGY & PHARMACY

影响因子: 最新[2024版] 最新五年平均 出版当年[2017版] 出版当年五年平均 出版前一年[2016版] 出版后一年[2018版]

第一作者:
第一作者单位: [1]Chongqing Univ, Chongqing Canc Inst, Key Lab Biorheol Sci & Technol, Minist Educ,Canc Hosp, Chongqing, Peoples R China [2]Chongqing Canc Hosp, Chongqing, Peoples R China
通讯作者:
通讯机构: [3]Huazhong Univ Sci & Technol,Tongji Med Coll,Tongji Hosp,Inst Organ Transplantat,Key Lab,Minist Hlth,Wuhan,Hubei,Peoples R China [4]Huazhong Univ Sci & Technol,Tongji Hosp,Tongji Med Coll,Minist Educ,Wuhan,Hubei,Peoples R China [*1]Huazhong Univ Sci & Technol,Inst Organ Transplantat,Tongji Med Coll,Key Lab,Minist Hlth,Minist Educ,Tongji Hosp,1095 Jiefang Ave,Wuhan 430030,Hubei,Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:622 今日访问量:0 总访问量:452 更新日期:2025-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)